Posters

This Stream includes all of our Posters Flipbooks

PharmaVOICE R&D Influencer: Jill Johnston
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Using PANSS Score Profiles to Predict Early Termination in a Study on Acute Exacerbation of Schizophrenia

Blinded analyses were aimed to determine how different atypical Positive and Negative Syndrome Scale (PANSS) score profiles (identified using algorithms) were able to predict early termination.
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Using scoring algorithms to identify serious scoring violations among placebo responders and non-responders in clinical trials using the Pos

The objective was to use a priori scoring algorithm designed to assess violations and non-violations on PANSS items.
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Validation of Goal Attainment Scaling for Depression: Initial Findings From an Open-Label Study in Patients Switching to Vortioxetine
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Clinical and Amyloid Screen Failure Rates in Episodic Memory Measures of Early AD Trials
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Independent Telephone-based Assessment of Depressive Symptoms in China
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Error Rates and Data Integrity: eCOA versus Paper Administration of the PANSS
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Independent Telephone-based Assessment of Depressive Symptoms in China
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Identifying Elevated Rates of CDR Scoring Errors

The goal of this study was to identify a CDR quality metric, based upon internal patterns of domain scores that could be used to identify atypical patterns that might be indicative of scoring errors.
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Increased Signal Detection in Alzheimer's Disease Clinical Trials

This study investigated the impact of lag time on error rates for commonly used Alzheimer’s disease COAs, as well as the degree to which administration attenuated error rates associated with lag time.
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
RBANS as a Useful Outcome Measure in Prodromal AD Trials

The goal of the present study was to examine the potential utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in prodromal AD trials.
- Facebook
- Twitter
- Email
- LinkedIn
Read Flipbook
Loading More...

Posters

PharmaVOICE R&D Influencer: Jill Johnston

Using PANSS Score Profiles to Predict Early Termination in a Study on Acute Exacerbation of Schizophrenia

Blinded analyses were aimed to determine how different atypical Positive and Negative Syndrome Scale (PANSS) score profiles (identified using algorithms) were able to predict early termination.

Using scoring algorithms to identify serious scoring violations among placebo responders and non-responders in clinical trials using the Pos

The objective was to use a priori scoring algorithm designed to assess violations and non-violations on PANSS items.

Validation of Goal Attainment Scaling for Depression: Initial Findings From an Open-Label Study in Patients Switching to Vortioxetine

Clinical and Amyloid Screen Failure Rates in Episodic Memory Measures of Early AD Trials

Independent Telephone-based Assessment of Depressive Symptoms in China

Error Rates and Data Integrity: eCOA versus Paper Administration of the PANSS

Independent Telephone-based Assessment of Depressive Symptoms in China

Identifying Elevated Rates of CDR Scoring Errors

The goal of this study was to identify a CDR quality metric, based upon internal patterns of domain scores that could be used to identify atypical patterns that might be indicative of scoring errors.

Increased Signal Detection in Alzheimer's Disease Clinical Trials

This study investigated the impact of lag time on error rates for commonly used Alzheimer’s disease COAs, as well as the degree to which administration attenuated error rates associated with lag time.

RBANS as a Useful Outcome Measure in Prodromal AD Trials

The goal of the present study was to examine the potential utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in prodromal AD trials.